Cases
Experience: Debt Offerings: Represented ARKO Corp. in its Rule 144A offering of $450 million of its 125% Senior Notes due 2029.
Represented TopBuild Corp. in its Rule 144A offering of $400 million of its 5.625% Senior Notes due 2026.
Represented Raymond James as placement agent in connection with $115 million private offering of senior secured notes by a private real estate company.
Represented investment banks in connection with a registered offering of an aggregate of $9 billion of senior notes, an aggregate of 1.5 billion of senior notes
an aggregate of 1.050 billion of senior notes, relating to an acquisition by the issuer.
Represented an issuer in connection with its registered offering of an aggregate of $2 billion of senior notes.
Represented investment banks in connection with a $1.75 billion Rule 144A /Regulation S offering of senior notes
a concurrent cash tender offer for $600 million of its outst
ing senior notes.
Represented an investment bank in 350 million Rule 144A /Regulation S offering of senior guaranteed notes relating to spin-off of a transportation system business from a public company.
Represented an investment bank regarding consent solicitation by an insurance company from the holders of its certain of its outst
ing notes to certain amendments under the indenture governing such notes.
Represented a financial institution relating to its $40 billion medium-term-notes program for 2017.
Equity Offerings: Represented Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) in its $450 million initial public offering.
Represented Enlivex Therapeutics (Nasdaq: ENLV) in connection with a $46 million underwritten offering of ordinary shares.
Represented The Music Acquisition Corporation (NYSE: TMAC) in its $200 million initial public offering.
Represented Barclays Capital Inc. in connection with the $115 million initial public offering of Motion Acquisition Corp. (Nasdaq: MOTN).
Represented H.C. Wainwright & Co. as underwriter in connection with a $30 million offering of American Depositary Shares by BioLineRx Ltd. (Nasdaq: BLRX).
Represented Raymond James as placement agent in connection with a $90 million offering of 7.00% Series C Cumulative Redeemable Preferred Stock by a REIT.
Represented Raymond James as placement agent in connection with a $125 million private offering of preferred membership interests by a private real estate company.
Represented Opko Health, Inc. (Nasdaq: OPK) in connection with a $75 million underwritten offering of common stock.
Represented a public company in a $776 million block trade by certain selling stockholders affiliated with a private equity firm, in order to sell stock obtained in connection with the sale of a portfolio company to the public company.
Represented an investment bank relating to a secondary offering of stock of a U.S. listed foreign private issuer.
Represented an investment bank in $124.8 million initial public offering of a financial institution.
Represented an insurance company in its $98 million Up-C initial public offering.
Represented issuers
investment banks in connection with At-The-Market offering programs.
Represented issuers
purchasers in connection with equity line programs.
The above representations were h
led by Mr. Rutherfurd prior to his joining Greenberg Traurig, P.A.
In-House Experience: Ongoing representation of several NYSE-
Nasdaq-traded public companies
Legal Secondee to Prime Brokerage of a financial institution in 2018
